Regorafenib and Nivolumab Simultaneous Combination Therapy

Clinical trial NCT03406871 · COMPLETED

Trial details

NCT number: NCT03406871
Sponsor: Kohei Shitara
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced and Metastatic Solid Tumor

Start date: 2018-01-15
Primary completion: 2020-12-15
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.